Jane Morgan’s Post

$BB1 - BlinkLab Limited, an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism, today announced that it initiated a clinical study in partnership with US based Turning Pointe Autism Foundation. The study will enroll up to one hundred children previously diagnosed with autism and one hundred children without an autism diagnosis. The data obtained during the course of this collaboration will be used to finalize the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024. Henk-Jan Boele, CEO of BlinkLab commented: “Our partnership with Turning Pointe is more than just collaboration. It is a major step toward fulfilling our mission to make well-established neurobehavioral testing clinically accessible and efficient. Turning Pointe’s dedication to quality education and support aligns perfectly with our goal of leveraging cutting-edge technology to better understand and assist individuals with autism. We are very excited about the possibilities that this collaboration offers for the advancement of autism diagnosis and care.” Brian Leedman, Chairman of BlinkLab commented: “I am excited to see that our first substantive news following our listing a few weeks ago is a collaboration with this prestigious group in the field of autism research in children. I anticipate many more important announcements such as these as we get closer to the commencement of our FDA registration study later this year”. Read more: https://lnkd.in/gtggKjrN Anton Uvarov PhD MBA Richard Hopkins #awareness #autismspeaks

BlinkLab Limited (ASX:BB1), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism, today announced that it initiated a clinical study in partnership with US based Turning Pointe Autism Foundation. The study will enroll up to one hundred children previously diagnosed with autism and one hundred children without an autism diagnosis. The data obtained during the course of this collaboration will be used to finalize the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024. Henk-Jan Boele, CEO of BlinkLab commented: “Our partnership with Turning Pointe is more than just collaboration. It is a major step toward fulfilling our mission to make well-established neurobehavioral testing clinically accessible and efficient. Turning Pointe’s dedication to quality education and support aligns perfectly with our goal of leveraging cutting-edge technology to better understand and assist individuals with autism. We are very excited about the possibilities that this collaboration offers for the advancement of autism diagnosis and care.” Brian Leedman, Chairman of BlinkLab commented: “I am excited to see that our first substantive news following our listing a few weeks ago is a collaboration with this prestigious group in the field of autism research in children. I anticipate many more important announcements such as these as we get closer to the commencement of our FDA registration study later this year”. Read more: https://lnkd.in/gq5RJsuU Anton Uvarov PhD MBA Richard Hopkins #awareness #autismspeaks

Deal Dive: EarliTec Diagnostics, Inc. Raises $21.5M to Revolutionize Autism Diagnosis. With 1 in 36 children in the U.S. diagnosed with autism, early diagnosis is critical for better developmental outcomes. EarliTec Diagnostics, Inc. just secured $21.5M in Series B funding to expand its AI-powered system that can diagnose autism in children as young as 16 months. EarliTec Diagnostics, Inc.’s breakthrough? A 12-minute test that tracks eye movements while children watch short videos, offering a quicker alternative to the traditional 3-4 hour assessment process. This innovation is already used by clinicians across six states, making faster diagnoses accessible to more families. Key reasons VCs are backing autism-focused tech Growing market awareness: Autism diagnoses have surged, revealing the scope of this unmet need. VC momentum: Recent funds, like the $60M Asociația IMPACT Autism Fund, highlight increasing interest in neurodiversity. Scalability: EarliTec Diagnostics, Inc.'s portable, tablet-based solution integrates seamlessly into existing clinical workflows. With this fresh capital, EarliTec Diagnostics, Inc. aims to expand its age range for diagnosis and refine treatment options, ensuring earlier and more accurate diagnoses for children. P.S. Do you think AI will become the standard in medical diagnostics? #AutismAwareness #HealthTech #AIforGood

“Autism represents an obvious area where innovation is going to transform the efficiency, the outcomes, and some of the other challenges with respect to how care is delivered today,” says JD Friedland, Managing Director, Cleveland Clinic Ventures, in a new article by Modern Healthcare exploring "Why Cleveland Clinic is investing in autism care startups". About 1 in 36 8-year-old children were estimated to have autism in 2020, up from 1 in 44 in 2018, according to the most recent data from the Centers for Disease Control and Prevention. Autism Eyes, created by Cleveland Clinic Innovations with intellectual property (IP) licensed from Cleveland Clinic, developed a diagnostic tool that uses artificial intelligence and eye-gaze tracking technology to assess if someone is at risk for autism spectrum disorder. Cleveland Clinic researchers found the eye-gazing technology could generate a diagnosis with 80% accuracy in less than 10 minutes. Autism Eyes has recently been acquired by the behavioral health-focused virtual reality company, Floreo. A new exclusive license between the Cleveland Clinic and Floreo has been entered to transfer the intellectual property. “It’s a large market with a huge unmet need and a lot of dissatisfaction with the current standard of care,” Friedland said. “And there’s a clear positive impact on the lives of patients by getting them diagnosed for proper treatment earlier.” https://hubs.li/Q02sycFZ0 #innovation #autism #neurodiversity #digitalhealth #healthtech #behavioralhealth #clevelandclinic #autismawarenessmonth #virtualreality

🌟 5 Global Trends in Autism Care to Watch in 2025  As we move towards 2025, the landscape of autism care is rapidly evolving. From digital transformation to groundbreaking therapy tools, here are the top 5 trends shaping autism care in 2025: Digital Transformation – Platforms like TherapEZ are streamlining admin and clinical tasks, saving time and reducing paperwork, so centers can focus on delivering quality care. 📊    Personalized Therapy with AI – AI-driven tools now help create tailored therapy plans by analyzing real-time data, ensuring treatments adapt to each child’s unique needs. 🤖    Telehealth & Remote Therapy – Families in remote areas can now access therapy from home, thanks to improved teletherapy platforms, making quality care accessible to all. 💻    Early Screening Innovations – New mobile-based tools are enhancing early autism diagnosis, leading to timely intervention and better developmental outcomes. 🧩    VR & AR in Therapy – Virtual and augmented reality are offering immersive, real-world practice scenarios, helping children build social skills and confidence. 🎮 These trends are creating a more accessible, personalized, and tech-driven autism care landscape. 🌐 If you’re in the autism care field, which trend excites you the most for 2025? Let’s discuss! #AutismCare #DigitalTransformation #Telehealth #PersonalizedTherapy #VRinTherapy #therapez #2025 

In a world where technology hugs humanity, there's a new beacon of hope ✨ for families touched by autism. Meet Forta: an AI-powered warrior in the domain of healthcare. Forta isn't just any tech tool – it’s a revolution wrapped in code, dedicated to shaping a new frontier in autism therapy 🧠. Traditionally, therapeutic interventions for autism have been as diverse as the spectrum itself. But, consistency and access have often been hurdles 🚧. Enter Forta, wielding technology to create personalizable, accessible, and steadfast support systems. Imagine a therapy companion that's unflagging, designed to understand and grow with each individual's unique journey 🌱. A partner that employs AI to refine approaches, ensuring that care is not just available, but is also tailored and empathetic. Now, that's a future we can all rally behind! This innovation is more than a leap; it's a commitment to redefining care 🤝. With each AI-driven insight, we're stepping closer to a world where the support for autism is as infinite as the potential within each person. Want to dive deep into this pioneering shift in healthcare? The full story awaits at the intersection of technology and empathy – and it's just a click away! Discover the empowering world of Forta on my tech, AI, Web3 website 💡. 👉 Explore the future of autism therapy: [Click here](https://lnkd.in/eYubDbDi) #AI #HealthcareInnovation #AutismSupport #TechnologyForGood #TransformingTherapy #InclusiveTech #Forta

Congratulations to Autism Eyes, an autism diagnostics and assessment company created by Cleveland Clinic Innovations with intellectual property (IP) licensed from Cleveland Clinic, which has been acquired by the behavioral health-focused virtual reality company, Floreo, led by CEO, Vijay Ravindran. This news coincides with an announcement that Cleveland Clinic has made a strategic investment in Floreo. The technology was invented by former Cleveland Clinic clinical psychologist and autism researcher, Tom Frazier, II, PhD, and Eric Klingemier. A new exclusive license between Cleveland Clinic and Floreo has been entered to transfer the IP. "The rising incidence of autism demands cutting-edge technology solutions to help individuals and their families, and Cleveland Clinic remains committed to driving innovations in autism treatment and services,” said Geoff Vince, PhD, Executive Director of Cleveland Clinic Innovations. “Floreo’s VR platform combined with the eye-tracking diagnostic capabilities of Autism Eyes will help build an integrated pathway tailored to each individual’s needs.” Floreo uses a virtual reality platform to help neurodiverse individuals develop new skills. The platform allows therapists to provide customized lessons to meet clients’ needs. The technology can be used in therapy, educational, or family settings. We are thrilled that this acquisition will help bolster Floreo's autism services! Read the full Behavioral Health Business piece: https://hubs.li/Q02ry-HZ0 #innovation #autism #neurodiversity #digitalhealth #healthtech #behavioralhealth #clevelandclinic #autismawarenessmonth #virtualreality

🚀 Excited to Share My Publication in NEJM-AI! 🌟 Early detection of autism is crucial for ensuring timely access to diagnostic evaluation and early intervention services, which significantly improve children's outcomes. This recent study on SenseToKnow, a mobile autism screening application is designed for smartphones and tablets. This app utilizes computer vision (CV) and machine learning (ML) to provide an objective assessment of early behavioral signs of autism. In our study, we examined the app’s accuracy when administered remotely by caregivers at home. The SenseToKnow app was used by caregivers of 620 toddlers aged 16 to 40 months, with 188 toddlers later diagnosed with autism by expert clinicians. Through engaging movies and a bubble-popping game, the app recorded children’s behavioral responses using the device’s front-facing camera and sensors. Here are some key findings: Diagnostic accuracy: Area under the ROC curve of 0.92 Sensitivity: 83.0% Specificity: 93.3% Positive predictive value: 84.3% Negative predictive value: 92.6% The results indicate that SenseToKnow can effectively support remote autism screening, potentially lowering barriers and improving early access to essential services. I believe this work has the potential to make a significant impact on early autism detection and support for families. 🌈 Free link to access: https://lnkd.in/ek3P2KKf #AutismAwareness #MobileHealth #Research #MachineLearning #ComputerVision #EarlyScreening #EarlyIntervention #HealthcareInnovation

🌟 AI Breakthrough in Autism Detection 🌟 Early detection of Autism Spectrum Disorder (ASD) just got a tech-driven boost! Researchers at the University of Arkansas are developing an AI-powered tool to identify early signs of autism by analyzing children’s responses to sensory cues. 👃 How it works: Through machine learning, subtle sensory and behavioral responses to specific smells and tastes, like peppermint and lemon—known triggers in children with ASD—are analyzed for unique patterns. The AI system then identifies atypical reactions that may point toward ASD. 🔍 Why it matters: Traditional autism screenings can be time-intensive and costly. This AI-based tool could provide a reliable, low-cost pre-screening, potentially accelerating the journey to diagnosis for families. 🚀 Impact: Imagine a world where parents have access to an efficient, first-step ASD screening tool. Early intervention and professional insights become more accessible, empowering families to act promptly. With AI, we’re getting closer to transforming autism detection into a faster, more inclusive process. 🙌 🔗 Curious about the broader potential of AI? 👉 https://lnkd.in/gq_qkiFg

Facial Recognition and Image Sensing ability with the help of AI is revolutionary